Preclinical evaluation of new formulation concepts for abiraterone acetate bioavailability enhancement based on the inhibition of pH-induced precipitation
Tereza Boleslavská, Svatopluk Světlík, Pavel Žvátora, Jan Bosák, Ondřej Dammer, Josef Beránek, Petr Kozlík, Tomáš Křížek, Nikolina Kutinová Canová, Martin Šíma, Ondřej Slanař, František Štĕpánek
Topics & Concepts
BioavailabilityAbiraterone acetatePharmacologyChemistryPharmacokineticsBioequivalenceDrugProtein precipitationDosage formChromatographyProstate cancerMedicineInternal medicineCancerAndrogen deprivation therapyDrug Solubulity and Delivery SystemsChemical Synthesis and AnalysisProtein purification and stability